Apr 10, 2024 / 08:00AM GMT
Operator
Good morning and welcome to the Futura Medical PLC for your results investor presentation. (Operator Instructions)
Before we begin, I would like to submit the following poll, and I would now like to hand you over to CEO, James Barder. Good morning to you.
James Barder - Futura Medical PLC - Group Chief Executive, Executive Director
Good morning. My name is James Barder and I am the CEO of Futura Medical. And I'm joined for today's presentation of the '23 yearend results, by Angela Hildreth, who is the Finance Director and Chief Operating Officer of Futura.
Futura specializes in the development and commercialization of innovative and proprietary section of products. Our lead product being Eroxon, a clinically proven breakthrough treatment for erectile dysfunction. We also describe ourselves as experts in research, development, and commercialization of topically delivered gel formulations.
I appreciate that for those longer-term shareholders, this is a change from Futura's previous focus. Following the success of Eroxon, this is a
Full Year 2023 Futura Medical PLC Earnings Call Transcript
Apr 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers